Immuron Limited (IMRN)
USD 1.92
(5.99%)
USD 1.92
(5.99%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 3.33 Million AUD | 154.88% |
| 2023 | 1.3 Million AUD | 150.07% |
| 2022 | 523.5 Thousand AUD | 452.77% |
| 2021 | 94.7 Thousand AUD | -94.82% |
| 2020 | 1.82 Million AUD | 6.38% |
| 2019 | 1.72 Million AUD | 76.87% |
| 2018 | 972.51 Thousand AUD | 88.65% |
| 2017 | 515.52 Thousand AUD | 19.64% |
| 2016 | 430.89 Thousand AUD | -12.61% |
| 2015 | 493.07 Thousand AUD | -30.69% |
| 2014 | 711.45 Thousand AUD | 1735.46% |
| 2013 | -43.5 Thousand AUD | -151.0% |
| 2012 | 85.29 Thousand AUD | 3270.82% |
| 2011 | -2690.00 AUD | -101.44% |
| 2010 | 186.46 Thousand AUD | -46.9% |
| 2009 | 351.16 Thousand AUD | 1505.55% |
| 2008 | 21.87 Thousand AUD | -94.78% |
| 2007 | 418.89 Thousand AUD | -70.61% |
| 2006 | 1.42 Million AUD | 164.71% |
| 2005 | -2.2 Million AUD | -266.5% |
| 2004 | 1.32 Million AUD | 0.0% |
| 2003 | - AUD | -100.0% |
| 2002 | 618.75 Thousand AUD | 289.87% |
| 2001 | -325.88 Thousand AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 790.17 Thousand AUD | -10.33% |
| 2024 Q4 | 1.75 Million AUD | 0.0% |
| 2024 FY | 3.33 Million AUD | 154.88% |
| 2024 Q2 | 1.58 Million AUD | 100.0% |
| 2023 Q3 | 564.98 Thousand AUD | 32.03% |
| 2023 Q4 | 881.22 Thousand AUD | 55.97% |
| 2023 Q2 | 427.92 Thousand AUD | 100.0% |
| 2023 Q1 | 213.96 Thousand AUD | -40.89% |
| 2023 FY | 1.3 Million AUD | 150.07% |
| 2022 FY | 523.5 Thousand AUD | 452.77% |
| 2022 Q4 | 361.95 Thousand AUD | 48.34% |
| 2022 Q3 | 243.99 Thousand AUD | 51.04% |
| 2022 Q1 | -28.48 Thousand AUD | -132.78% |
| 2022 Q2 | 161.54 Thousand AUD | 667.2% |
| 2021 Q2 | 7825.00 AUD | 108.1% |
| 2021 Q1 | -96.65 Thousand AUD | -113.65% |
| 2021 FY | 94.7 Thousand AUD | -94.82% |
| 2021 Q4 | 86.88 Thousand AUD | 136.83% |
| 2021 Q3 | -235.87 Thousand AUD | -3114.36% |
| 2020 Q3 | 354.15 Thousand AUD | -68.42% |
| 2020 Q1 | 560.71 Thousand AUD | -42.23% |
| 2020 FY | 1.82 Million AUD | 6.38% |
| 2020 Q4 | 708.3 Thousand AUD | 100.0% |
| 2020 Q2 | 1.12 Million AUD | 100.0% |
| 2019 Q3 | 479.95 Thousand AUD | 28.54% |
| 2019 Q2 | 373.37 Thousand AUD | 0.0% |
| 2019 Q4 | 970.66 Thousand AUD | 102.24% |
| 2019 Q1 | 373.37 Thousand AUD | 6.61% |
| 2019 FY | 1.72 Million AUD | 76.87% |
| 2018 FY | 972.51 Thousand AUD | 88.65% |
| 2018 Q1 | 280.09 Thousand AUD | -3.02% |
| 2018 Q4 | 350.21 Thousand AUD | 0.0% |
| 2018 Q3 | 350.21 Thousand AUD | 25.04% |
| 2018 Q2 | 280.09 Thousand AUD | 0.0% |
| 2017 Q2 | 172.26 Thousand AUD | -0.0% |
| 2017 FY | 515.52 Thousand AUD | 19.64% |
| 2017 Q1 | 172.26 Thousand AUD | -2.14% |
| 2017 Q4 | 288.81 Thousand AUD | 0.0% |
| 2017 Q3 | 288.81 Thousand AUD | 67.65% |
| 2016 Q1 | 171.7 Thousand AUD | 14.99% |
| 2016 Q4 | 176.02 Thousand AUD | 0.0% |
| 2016 Q3 | 176.02 Thousand AUD | 2.52% |
| 2016 Q2 | 171.7 Thousand AUD | 0.0% |
| 2016 FY | 430.89 Thousand AUD | -12.61% |
| 2015 FY | 493.07 Thousand AUD | -30.69% |
| 2015 Q4 | 149.32 Thousand AUD | 0.0% |
| 2015 Q3 | 149.32 Thousand AUD | -15.22% |
| 2015 Q2 | 176.13 Thousand AUD | -0.0% |
| 2015 Q1 | 176.13 Thousand AUD | -18.49% |
| 2014 Q1 | 139.64 Thousand AUD | 1246.89% |
| 2014 FY | 711.45 Thousand AUD | 1735.46% |
| 2014 Q4 | 216.08 Thousand AUD | 0.0% |
| 2014 Q3 | 216.08 Thousand AUD | 54.74% |
| 2014 Q2 | 139.64 Thousand AUD | -0.0% |
| 2013 FY | -43.5 Thousand AUD | -151.0% |
| 2013 Q4 | -12.17 Thousand AUD | 0.0% |
| 2013 Q3 | -12.17 Thousand AUD | -141.64% |
| 2013 Q1 | 29.24 Thousand AUD | 0.0% |
| 2013 Q2 | 29.24 Thousand AUD | 0.0% |
| 2012 FY | 85.29 Thousand AUD | 3270.82% |
| 2011 FY | -2690.00 AUD | -101.44% |
| 2010 FY | 186.46 Thousand AUD | -46.9% |
| 2009 FY | 351.16 Thousand AUD | 1505.55% |
| 2008 FY | 21.87 Thousand AUD | -94.78% |
| 2007 FY | 418.89 Thousand AUD | -70.61% |
| 2006 FY | 1.42 Million AUD | 164.71% |
| 2005 FY | -2.2 Million AUD | -266.5% |
| 2004 FY | 1.32 Million AUD | 0.0% |
| 2003 FY | - AUD | -100.0% |
| 2002 FY | 618.75 Thousand AUD | 289.87% |
| 2001 FY | -325.88 Thousand AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 3539.997% |
| Psyence Biomedical Ltd. | -240.00 USD | 1390432.083% |
| XOMA Corporation | 3.86 Million USD | 13.577% |
| Mesoblast Limited | -9.81 Million USD | 133.997% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 97.533% |
| Aptorum Group Limited | -1.11 Million USD | 399.348% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 74333.526% |
| HilleVax, Inc. | -2.15 Million USD | 254.768% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 147.01% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 110.706% |
| Precision BioSciences, Inc. | 40.47 Million USD | 91.755% |
| Dyadic International, Inc. | 922.95 Thousand USD | -261.533% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 2369.93% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 103.144% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 84.157% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -686.98% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 91.937% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 96.477% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 138.411% |
| IGM Biosciences, Inc. | -211.66 Million USD | 101.576% |
| Opthea Limited | 21.72 Thousand USD | -15262.785% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -730.049% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -37.035% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -10.234% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 97.214% |
| NextCure, Inc. | -3.68 Million USD | 190.575% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 124.98% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 376.94% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 83.359% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 97.844% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 103.397% |
| Senti Biosciences, Inc. | -2.68 Million USD | 224.368% |
| Apollomics, Inc. | 127 Thousand USD | -2527.399% |
| PureTech Health plc | -1.6 Million USD | 308.16% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 111.519% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -316.059% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 103.02% |
| ChromaDex Corporation | 50.78 Million USD | 93.429% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 97.23% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 107.362% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 153.303% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 103.399% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -2680.664% |
| Fortress Biotech, Inc. | 57.85 Million USD | 94.232% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 107.677% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 14607.813% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -2466.767% |
| Celcuity Inc. | -142.77 Thousand USD | 2437.151% |
| ContextLogic Inc. | 59 Million USD | 94.344% |
| GH Research PLC | -315 Thousand USD | 1159.301% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 79.871% |
| Cassava Sciences, Inc. | -89.42 Million USD | 103.731% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -757.788% |
| ImmuCell Corporation | 4.39 Million USD | 24.1% |
| Amarin Corporation plc | 165.54 Million USD | 97.984% |
| TG Therapeutics, Inc. | 219.1 Million USD | 98.477% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 267.174% |
| Acelyrin, Inc. | -115 Thousand USD | 3001.563% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Seer, Inc. | 7.02 Million USD | 52.515% |
| Novavax, Inc. | 639.93 Million USD | 99.479% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -547.922% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 99.902% |
| AnaptysBio, Inc. | 14.78 Million USD | 77.425% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 688.5% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 365.457% |
| AbCellera Biologics Inc. | 38.02 Million USD | 91.225% |
| CorMedix Inc. | -205.56 Thousand USD | 1723.256% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 86.353% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 146.96% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 99.97% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 803.157% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 32184.587% |
| Soligenix, Inc. | 97.31 Thousand USD | -3329.003% |
| Century Therapeutics, Inc. | -10.8 Million USD | 130.871% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 98.614% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 745.733% |
| Kura Oncology, Inc. | -849 Thousand USD | 493.027% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 193.968% |
| Ardelyx, Inc. | 106.66 Million USD | 96.872% |
| Ainos, Inc. | -253.73 Thousand USD | 1415.082% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 104.973% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| Prothena Corporation plc | -129.2 Million USD | 102.583% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 96.631% |
| Autolus Therapeutics plc | -4.86 Million USD | 168.56% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 93.383% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 2086.189% |
| Celularity Inc. | 6.75 Million USD | 50.603% |
| Rallybio Corporation | -150 Thousand USD | 2324.531% |
| GRI Bio, Inc. | 10.84 Million USD | 69.221% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -31.371% |
| Omeros Corporation | -69.77 Million USD | 104.782% |
| INmune Bio, Inc. | 155 Thousand USD | -2052.772% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 94.613% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 321.524% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 614.577% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 11498.5% |
| Humacyte, Inc. | -76.55 Million USD | 104.359% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 1166.069% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 96.468% |
| Immunocore Holdings plc | 248.39 Million USD | 98.657% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 121.997% |
| Verastem, Inc. | -62 Thousand USD | 5481.931% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 1378.466% |
| Histogen Inc. | 3.76 Million USD | 11.467% |
| Surrozen, Inc. | -27.23 Million USD | 112.254% |
| Blueprint Medicines Corporation | 236.58 Million USD | 98.59% |
| Organovo Holdings, Inc. | -5.38 Million USD | 161.919% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| IO Biotech, Inc. | -756 Thousand USD | 541.375% |
| MEI Pharma, Inc. | 49.32 Million USD | 93.235% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 44.996% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 5070.575% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 333.997% |
| Summit Therapeutics Inc. | -2.05 Million USD | 262.771% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 169.546% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 88.516% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -2188.612% |
| Turnstone Biologics Corp. | 16.5 Million USD | 79.784% |
| Pulmatrix, Inc. | -8.22 Million USD | 140.594% |
| Synaptogenix, Inc. | -6347.00 USD | 52672.822% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 6642.739% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 97.932% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 936.29% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 100.837% |
| Cytokinetics, Incorporated | -322.59 Million USD | 101.034% |
| Exelixis, Inc. | 1.75 Billion USD | 99.81% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 102.975% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 99.013% |
| Evogene Ltd. | 1.39 Million USD | -138.513% |
| Replimune Group, Inc. | -2.65 Million USD | 225.68% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 5920.739% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 401.155% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 2916.076% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 1.1 Million USD | -201.155% |
| Avid Bioservices, Inc. | 7.31 Million USD | 54.403% |
| Insmed Incorporated | 239.63 Million USD | 98.608% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -572.741% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 340.23% |
| Sagimet Biosciences Inc. | 2 Million USD | -66.84% |
| MediWound Ltd. | 3.57 Million USD | 6.741% |
| MiMedx Group, Inc. | 266.84 Million USD | 98.75% |
| OmniAb, Inc. | 14.66 Million USD | 77.25% |
| Alector, Inc. | -95.05 Million USD | 103.51% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 97.344% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 99.617% |
| Mereo BioPharma Group plc | 7.42 Million USD | 55.066% |
| Zai Lab Limited | 170.9 Million USD | 98.048% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 95.925% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 27906.642% |
| Aura Biosciences, Inc. | -1.29 Million USD | 357.668% |
| Immunic, Inc. | -111 Thousand USD | 3106.123% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 235.587% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 78.953% |
| Veracyte, Inc. | 248.14 Million USD | 98.655% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 100.048% |
| FibroGen, Inc. | 128.9 Million USD | 97.411% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Allakos Inc. | -6.14 Million USD | 154.336% |
| scPharmaceuticals Inc. | 9.78 Million USD | 65.888% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 104.836% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 99.299% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 591730.674% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 29349.623% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 128.601% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 99.061% |
| Precigen, Inc. | 106 Thousand USD | -3047.922% |
| Fortrea Holdings Inc. | 424 Million USD | 99.213% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 103.872% |
| Incyte Corporation | 3.44 Billion USD | 99.903% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 6676.265% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 77.445% |
| XBiotech Inc. | -1.74 Million USD | 291.33% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 73.22% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 401.155% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 240.95 Million USD | 98.615% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 11606.197% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 107.18% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 104.418% |
| Agenus Inc. | 139.61 Million USD | 97.61% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 182.86% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 95.454% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 80.142% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 99.142% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 106.721% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -1613.744% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 98.979% |
| UroGen Pharma Ltd. | 73.35 Million USD | 95.451% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 129.467% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 112.5% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -61692.537% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 1865.501% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 5093.187% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 17.63% |
| Chimerix, Inc. | 324 Thousand USD | -929.876% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 735.58% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 7651.365% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 1610.02% |
| Pluri Inc. | 322 Thousand USD | -936.272% |
| Cue Biopharma, Inc. | -32.6 Million USD | 110.233% |
| MeiraGTx Holdings plc | 287 Thousand USD | -1062.647% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -479.125% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 168625.101% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 94.651% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 131.946% |
| CalciMedica, Inc. | -58 Thousand USD | 5853.098% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 217.328% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 110.811% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 385.196% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 29349.623% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -20.22% |
| Nutriband Inc. | 862.1 Thousand USD | -287.052% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 1078.533% |
| Vor Biopharma Inc. | -3.49 Million USD | 195.555% |
| Roivant Sciences Ltd. | 109.23 Million USD | 96.945% |
| ProKidney Corp. | -3.16 Million USD | 205.295% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 107.599% |
| Daré Bioscience, Inc. | 2.76 Million USD | -20.483% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 51.337% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 292.99% |
| Bicycle Therapeutics plc | -129.52 Million USD | 102.576% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 104.241% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 10211.506% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 100.835% |
| Atai Life Sciences N.V. | -5000.00 USD | 66835.94% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 2838.244% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 3575.83% |
| MediciNova, Inc. | 979.7 Thousand USD | -240.592% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 103.957% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 3628.948% |
| GeoVax Labs, Inc. | -20.72 Million USD | 116.104% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 94.114% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 98.635% |
| Biomea Fusion, Inc. | -4.2 Million USD | 179.429% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Erasca, Inc. | -3.73 Million USD | 189.41% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 1176.386% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 66835.94% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 104.369% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 98.439% |
| bluebird bio, Inc. | -4.03 Million USD | 182.799% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 454.601% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -230.703% |
| Imunon, Inc. | -720 Thousand USD | 563.441% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 99.825% |
| BioAtla, Inc. | -103.73 Million USD | 103.217% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 101.374% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 1172.925% |
| DBV Technologies S.A. | 15.72 Million USD | 78.784% |
| Fortress Biotech, Inc. | 57.85 Million USD | 94.232% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 101.839% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 104.761% |
| aTyr Pharma, Inc. | -2.38 Million USD | 239.732% |
| Viridian Therapeutics, Inc. | -1 Million USD | 431.031% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -25667569.231% |
| Galecto, Inc. | -830 Thousand USD | 502.024% |
| Akari Therapeutics, Plc | -4000.00 USD | 83519.925% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 99.476% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -198.195% |
| Entera Bio Ltd. | -56 Thousand USD | 6058.566% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 97.506% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 684.378% |
| Xencor, Inc. | -85.26 Million USD | 103.914% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -29.635% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 108.481% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 433.268% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 98.124% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -1613.744% |
| Portage Biotech Inc. | -54 Thousand USD | 6279.254% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 3628.948% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 985.092% |
| OncoCyte Corporation | 413 Thousand USD | -707.941% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 1503161.712% |
| Purple Biotech Ltd. | -196 Thousand USD | 1802.447% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 62.792% |
| Onconetix, Inc. | -1.12 Million USD | 396.034% |
| MacroGenics, Inc. | 50.52 Million USD | 93.396% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 22339.383% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 599.521% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 82.478% |
| Prime Medicine, Inc. | -147.9 Million USD | 102.256% |
| Aditxt, Inc. | -111.66 Thousand USD | 3088.355% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 44554.115% |
| Savara Inc. | -44.26 Million USD | 107.539% |
| Curis, Inc. | 9.81 Million USD | 65.989% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 2773.973% |
| Adagene Inc. | 18.11 Million USD | 81.576% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 1563.507% |
| BeiGene, Ltd. | 2.07 Billion USD | 99.839% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -447.914% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 2428.523% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 97.62% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 11925.066% |
| SciSparc Ltd. | 2.19 Million USD | -51.949% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 11925.066% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 464.677% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 13421.079% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 10870.115% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 58.321% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 93.891% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 722.537% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 99.78% |
| ADMA Biologics, Inc. | 88.21 Million USD | 96.218% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 96.96% |
| Clene Inc. | 533 Thousand USD | -526.041% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 103.003% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 192.999% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 448.673% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -67.847% |
| Adicet Bio, Inc. | -6.09 Million USD | 154.72% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 93.3% |
| Absci Corporation | -41.84 Million USD | 107.973% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -583.77% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 97.886% |
| Surrozen, Inc. | -27.23 Million USD | 112.254% |
| Generation Bio Co. | -73.91 Million USD | 104.515% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 104.3% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 863.569% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 107.124% |
| Invivyd, Inc. | -2.02 Million USD | 264.536% |
| Cingulate Inc. | -582.91 Thousand USD | 672.43% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 101.109% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 3325.891% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 44179.221% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 96.537% |
| Jaguar Health, Inc. | 7.72 Million USD | 56.8% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 96.605% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 57.606% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 478.751% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 99.51% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 86.16% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 1817.201% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 1.37 Million USD | -143.207% |
| Innoviva, Inc. | 261.06 Million USD | 98.722% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 106.218% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 88.545% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 499.138% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 96.0% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -4463.953% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 93.723% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 101.927% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 1045.268% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 10863.861% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 116.939% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 437.732% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 6022.397% |
| AlloVir, Inc. | -398 Thousand USD | 938.391% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 423.333% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 98.936% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 1242.739% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 602.53% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 16.85% |
| ImmunityBio, Inc. | -17.89 Million USD | 118.652% |
| Korro Bio, Inc. | -3.63 Million USD | 191.923% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 103.442% |
| Kineta, Inc. | 5.43 Million USD | 38.583% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 2008.453% |
| BioVie Inc. | -229.37 Thousand USD | 1554.722% |
| Codexis, Inc. | 57.33 Million USD | 94.18% |
| Celularity Inc. | 6.75 Million USD | 50.603% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 992.192% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -6495.764% |
| Kodiak Sciences Inc. | -25.94 Million USD | 112.86% |
| Cibus, Inc. | 1.42 Million USD | -134.655% |
| Annexon, Inc. | -3.26 Million USD | 202.136% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 107.995% |
| Moderna, Inc. | 2.15 Billion USD | 99.845% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 99.571% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 263.248% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -421.375% |
| Immix Biopharma, Inc. | -5468.00 USD | 61124.086% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 98.071% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 153.629% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 96.795% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 275.621% |
| Alkermes plc | 1.37 Billion USD | 99.757% |
| Arcellx, Inc. | 108.27 Million USD | 96.918% |
| Moolec Science SA | -143.3 Thousand USD | 2428.458% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 110.309% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -1.515% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 95.787% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 115.775% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 104.761% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 276.55% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 92480.869% |
| Humacyte, Inc. | -76.55 Million USD | 104.359% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 107.885% |
| Geron Corporation | -123.5 Million USD | 102.702% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 23.783% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Royalty Pharma plc | 1.79 Billion USD | 99.814% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -1342.06% |
| Notable Labs, Ltd. | 113 Thousand USD | -2852.918% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 102.995% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 451.547% |
| IN8bio, Inc. | -2.5 Million USD | 233.419% |
| 89bio, Inc. | -273 Thousand USD | 1322.27% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 11222.657% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -79.205% |
| Acasti Pharma Inc. | -11 Thousand USD | 30434.518% |
| Genelux Corporation | -848 Thousand USD | 493.49% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 2812.843% |
| Liquidia Corporation | 14.6 Million USD | 77.145% |
| Mustang Bio, Inc. | -2.22 Million USD | 249.968% |
| Immunovant, Inc. | -231 Thousand USD | 1544.501% |
| Vericel Corporation | 135.57 Million USD | 97.539% |
| Quantum-Si incorporated | 488 Thousand USD | -583.77% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 106.006% |
| XOMA Corporation | 3.86 Million USD | 13.577% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 116.654% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 1730.753% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 614.577% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 410.689% |
| Vaxcyte, Inc. | -75 Million USD | 104.449% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 101.992% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 975.8% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 115.176% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 95.102% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 270.419% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 499.616% |
| PepGen Inc. | -1.18 Million USD | 381.824% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 2727.399% |
| United Therapeutics Corporation | 2.07 Billion USD | 99.839% |
| Solid Biosciences Inc. | -76.56 Million USD | 104.358% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 4140.537% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Immuneering Corporation | -764.13 Thousand USD | 536.675% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -4935.611% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 184.646% |
| Belite Bio, Inc | -399 Thousand USD | 936.29% |
| Pharming Group N.V. | 220.1 Million USD | 98.484% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | -434.44 Thousand USD | 868.053% |
| Pyxis Oncology, Inc. | -2 Million USD | 266.84% |
| uniQure N.V. | 2.21 Million USD | -50.645% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 4169.265% |
| GeoVax Labs, Inc. | -20.72 Million USD | 116.104% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 103.624% |
| Altimmune, Inc. | -65.37 Million USD | 105.104% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 410.689% |
| Peak Bio, Inc. | 367.76 Thousand USD | -807.308% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 863.569% |
| Benitec Biopharma Inc. | 108 Thousand USD | -2989.627% |
| Zura Bio Limited | - USD | -Infinity% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 99.078% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 33298.657% |
| Compugen Ltd. | 31.45 Million USD | 89.392% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -194.1% |
| argenx SE | 1.1 Billion USD | 99.699% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 86.389% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 114.573% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 4377.945% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 377.373% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 733.168% |
| PolyPid Ltd. | -1.82 Million USD | 283.139% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 2904.031% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 169.851% |
| Forte Biosciences, Inc. | -9000.00 USD | 37175.522% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -35.038% |
| Instil Bio, Inc. | -4.75 Million USD | 170.16% |
| Elevation Oncology, Inc. | -39 Thousand USD | 8655.89% |
| Immunome, Inc. | -8.9 Million USD | 137.463% |
| Verona Pharma plc | -679.62 Thousand USD | 590.977% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 917.782% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 2006.741% |
| Shattuck Labs, Inc. | -2.38 Million USD | 239.908% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 238.629% |
| Design Therapeutics, Inc. | -537 Thousand USD | 721.377% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 881.451% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -55.489% |
| Achilles Therapeutics plc | -4.73 Million USD | 170.526% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -7659.993% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 505.936% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 25459.454% |
| Beam Therapeutics Inc. | -59.67 Million USD | 105.592% |
| Moolec Science SA | -143.3 Thousand USD | 2428.458% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 66835.94% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 84.512% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 1223.501% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 134.882% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 76.301% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 224.902% |
| Athira Pharma, Inc. | -969 Thousand USD | 444.355% |
| HCW Biologics Inc. | -574.82 Thousand USD | 680.49% |
| XOMA Corporation | 3.86 Million USD | 13.577% |
| NeurAxis, Inc. | 2.15 Million USD | -54.717% |
| Lumos Pharma, Inc. | 2 Million USD | -66.258% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 2006.741% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 3257.603% |
| Nektar Therapeutics | 53.47 Million USD | 93.76% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 377.373% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 89.46% |
| Arvinas, Inc. | 71.8 Million USD | 95.353% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Palisade Bio, Inc. | 246 Thousand USD | -1256.422% |
| Nutriband Inc. | 862.1 Thousand USD | -287.052% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 107.326% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 10211.506% |
| Merus N.V. | -83.46 Million USD | 103.998% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 105.315% |
| Neurogene Inc. | -3.26 Million USD | 202.293% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 97.605% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 6166.904% |
| CervoMed Inc. | -1.29 Million USD | 357.941% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 190.379% |
| Sesen Bio, Inc. | 40 Million USD | 91.658% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 1136.272% |
| Rezolute, Inc. | -36 Thousand USD | 9368.881% |
| Clene Inc. | 533 Thousand USD | -526.041% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 259975.156% |
| BeyondSpring Inc. | 1.75 Million USD | -90.565% |
| Synlogic, Inc. | -1.92 Million USD | 273.43% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 9118.37% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 152.697% |
| Peak Bio, Inc. | 367.76 Thousand USD | -807.308% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 117.596% |
| Krystal Biotech, Inc. | 47.6 Million USD | 92.991% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 97.635% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 33.596% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 228.873% |
| MannKind Corporation | 136.19 Million USD | 97.55% |
| Ikena Oncology, Inc. | -50.49 Million USD | 106.609% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 96.933% |
| Gossamer Bio, Inc. | -4.38 Million USD | 176.096% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 1424.126% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 66835.94% |
| Legend Biotech Corporation | 140.92 Million USD | 97.632% |
| Mural Oncology plc | -2.56 Million USD | 229.988% |
| Disc Medicine, Inc. | -100 Thousand USD | 3436.797% |
| Champions Oncology, Inc. | 20.75 Million USD | 83.922% |
| REGENXBIO Inc. | 53.02 Million USD | 93.708% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 162.289% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 1834.527% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 292.656% |
| Vaxart, Inc. | -60.76 Million USD | 105.491% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 1369.806% |
| Cellectis S.A. | 18 Thousand USD | -18437.761% |
| Longeveron Inc. | 221 Thousand USD | -1409.863% |
| Repare Therapeutics Inc. | -80.07 Million USD | 104.167% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 99.695% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 357.867% |
| Revolution Medicines, Inc. | -399.66 Million USD | 100.835% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 9633.706% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -6709.79% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 99.961% |
| Denali Therapeutics Inc. | -93.34 Million USD | 103.575% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 13421.079% |
| Veru Inc. | 7.56 Million USD | 55.897% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 2309.799% |
| Cingulate Inc. | -582.91 Thousand USD | 672.43% |
| Passage Bio, Inc. | -3.72 Million USD | 189.675% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 27805.056% |
| Exicure, Inc. | -1.42 Million USD | 334.49% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 971.226% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -23.448% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 750.86% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 2330.375% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 105.636% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -753.401% |
| OmniAb, Inc. | 14.66 Million USD | 77.25% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 83.31% |
| Lipocine Inc. | -2.85 Million USD | 217.047% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 281.052% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 158.489% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 321.524% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 95.57% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 5233.534% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 96.042% |
| Ocugen, Inc. | -33.53 Million USD | 109.95% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 205.528% |
| Q32 Bio Inc. | 578 Thousand USD | -477.301% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 1359.169% |
| Alumis Inc. Common Stock | -1.28 Million USD | 359.875% |
| Equillium, Inc. | 35.95 Million USD | 90.72% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 295.477% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -566.454% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 80815.941% |
| Dominari Holdings Inc. | 2.03 Million USD | -63.649% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 1918.705% |
| vTv Therapeutics Inc. | -13.59 Million USD | 124.544% |
| Bio-Techne Corporation | 773.07 Million USD | 99.568% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 80.733% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 99.276% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 385.44% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 113.915% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 71.473% |
| Nkarta, Inc. | -5.86 Million USD | 156.855% |
| BioCardia, Inc. | -7.24 Million USD | 146.031% |
| Iterum Therapeutics plc | -1.75 Million USD | 290.674% |